Streptococcus thermophilus: Evidence-Based Benefits for Gut Health and Immunity
What the science says about one of the most underappreciated strains in modern probiotic research
If you've ever eaten yogurt, you've already consumed Streptococcus thermophilus. It's one of the two original yogurt starter bacteria responsible for fermenting dairy into one of humanity's oldest functional foods, and it has been a part of the human food supply for millennia. Its history in fermented milk and fermented dairy products, however, is just the beginning of the story. Over the past two decades, researchers have published an expanding body of evidence showing that S. thermophilus actively supports gut integrity, modulates immune function, reduces inflammation, and may even play a protective role against colorectal cancer development.
Despite this, Streptococcus thermophilus is often overshadowed by its more widely marketed counterparts—the lactobacilli and bifidobacteria that dominate probiotic label claims. It belongs to the larger family of lactic acid bacteria (LAB), a functionally diverse group of microorganisms characterized by the production of lactic acid through carbohydrate fermentation, and it is among the most thoroughly studied members of that group. The name doesn't help consumer perception. "Streptococcus" sounds like a pathogen to most people, and that association alone causes many to overlook one of the most rigorously safety-confirmed strains in the probiotic world. This article corrects that misunderstanding, drawing on peer-reviewed research to explore what S. thermophilus actually does—and why it earned its place in MicroBiome Restore's 26-strain formula.
Key Takeaways
- Streptococcus thermophilus is not a pathogen—it holds both GRAS (Generally Recognized As Safe) status in the United States and Qualified Presumption of Safety (QPS) status in the European Union, making it among the most thoroughly vetted organisms in the food and supplement industry.[1]
- S. thermophilus produces beta-galactosidase (lactase), allowing it to break down lactose during digestion. Multiple clinical studies confirm it significantly reduces lactose intolerance symptoms when consumed in fermented dairy products.[2][3]
- Research demonstrates that S. thermophilus modulates the immune system at the gene expression level, influencing both innate and adaptive immunity through interactions with peripheral blood mononuclear cells.[4]
- S. thermophilus produces exopolysaccharides (EPS)—bioactive compounds that support gut barrier integrity, interact with mucosal immune cells, and exhibit anti-inflammatory properties in macrophage models.[5]
- In combination with Bifidobacterium breve, S. thermophilus supplementation has been shown to attenuate exercise-induced muscle damage and inflammation in controlled clinical trials.[6]
- MicroBiome Restore includes S. thermophilus as one of 26 clinically relevant probiotic strains delivering 15 billion CFU per serving—alongside the prebiotic substrates that help this strain thrive in the large intestine.
What Is Streptococcus thermophilus?
Streptococcus thermophilus is a Gram-positive, thermophilic lactic acid bacterium—"thermophilus" literally means "heat-loving," reflecting its optimal growth temperature of approximately 40–45°C. As a member of the lactic acid bacteria group, it shares metabolic traits with other Lactobacillus and Bifidobacterium species, but it occupies a taxonomically and functionally distinct position. Unlike pathogenic members of the Streptococcus genus such as S. pyogenes or S. pneumoniae, S. thermophilus belongs to the viridans group and is entirely non-pathogenic. It produces lactic acid through the fermentation of lactose, which is precisely why dairy cultures have relied on it for centuries.
Safety Status: GRAS and QPS
One of the most important facts about S. thermophilus is its dual regulatory safety certification. In the United States, the FDA classifies it as GRAS—Generally Recognized As Safe—a designation based on decades of safe human consumption and scientific evaluation. In the European Union, the European Food Safety Authority (EFSA) has granted it QPS (Qualified Presumption of Safety) status, a designation reserved for microorganisms with a well-established history of safe use and no known safety concerns at the species level.[1]
This matters enormously when you see "Streptococcus" on a supplement label and instinctively hesitate. The QPS and GRAS designations mean regulatory scientists on both sides of the Atlantic have reviewed the evidence and concluded this strain is safe for human consumption—a standard that many other common probiotic ingredients, including synthetic fillers and flow agents, cannot match. As we explain in our article on common fillers and flow agents in probiotics, not everything in a supplement capsule deserves the benefit of the doubt the way S. thermophilus does.
A Brief History: From Yogurt to Supplement
S. thermophilus and Lactobacillus delbrueckii subsp. bulgaricus—both of which are included in MicroBiome Restore—are the legally mandated yogurt starter bacteria for yogurt production throughout much of the world. These two lactic acid bacteria have been used together in fermented milk production for thousands of years, with their co-fermentation predating modern microbiology. It was only in the 20th century that researchers began systematically examining why populations consuming these fermented foods appeared to benefit from improved digestive health, and the scientific literature on S. thermophilus has accelerated dramatically since.

The Thermophilic Advantage
S. thermophilus thrives in conditions that would stress or kill most mesophilic lactobacilli—it can withstand temperatures up to 65°C, making it unusually resilient during the manufacturing and encapsulation of probiotic supplements. This thermal tolerance is one reason it has been studied extensively as a starter culture and suggests it may be more stable in storage conditions than many competing strains. The pullulan capsules used in MicroBiome Restore complement this stability by providing delayed release that protects all strains through the acidic stomach environment.
How It Produces Probiotic Effects
Unlike some probiotics that primarily function by colonizing and displacing harmful bacteria, S. thermophilus works through several distinct mechanisms across the gastrointestinal tract. It produces beta-galactosidase to digest lactose; synthesizes exopolysaccharides (EPS) that interact directly with intestinal epithelial and immune cells; produces extracellular folic acid (vitamin B9), making it one of the few probiotic strains that contributes meaningfully to B-vitamin status; and generates short-chain fatty acids through fermentation that fuel colonocytes. Its probiotic potential also includes demonstrated resistance to bile salts—the harsh digestive fluid secreted into the small intestine that eliminates many less resilient bacterial strains before they can exert their effects. It also demonstrates significant viability through the full gastrointestinal transit, a critical requirement for any meaningful probiotic claim.
Streptococcus thermophilus Benefits for Gut Health
Lactose Intolerance: The Most Clinically Documented Benefit
The most thoroughly established benefit of S. thermophilus is its ability to reduce lactose intolerance symptoms. A pivotal study published in the New England Journal of Medicine by Kolars and colleagues established that yogurt cultures—particularly the beta-galactosidase produced by S. thermophilus—serve as an "autodigestive source of lactose," meaning the bacteria effectively pre-digest the lactose within the fermented product before and during digestion.[2]
This finding has been replicated and expanded upon across multiple subsequent investigations. A review published in the American Journal of Clinical Nutrition confirmed that consuming S. thermophilus-containing dairy significantly reduces breath hydrogen excretion—a validated biomarker of lactose maldigestion—compared with unfermented milk consumption in lactase-deficient adults.[3] The mechanism is well-understood: S. thermophilus produces intracellular beta-galactosidase that is released into the small intestine as bacteria lyse during digestion, supplementing the host's own lactase activity.
For those who have struggled with dairy-related bloating and discomfort, this is significant beyond dairy alone. It suggests S. thermophilus contributes meaningfully to the broader fermentative capacity of the gut, and understanding which probiotic strains address bloating at the clinical level is an important part of choosing the right supplement.

Intestinal Barrier Integrity and the Gut Lining
Emerging research highlights S. thermophilus' role in supporting the structural integrity of the intestinal epithelium. The exopolysaccharides (EPS) this strain produces are not merely fermentation byproducts—they are bioactive compounds that adhere to mucin and interact with intestinal epithelial cells in ways that support tight junction proteins. Tight junctions are the molecular "seals" between intestinal epithelial cells that prevent undigested food particles and bacterial components from crossing into the bloodstream.
When tight junction integrity is compromised—a condition commonly called "leaky gut"—inflammatory signaling can propagate systemically. The EPS produced by S. thermophilus has been shown to stimulate mucus production and support goblet cell function, both of which are critical for maintaining the protective mucus layer that lines the gut. Our article on gut bacteria and the mucosal lining explores these mechanisms in more depth.
IBS, Diarrhea, and Inflammatory Bowel Conditions
S. thermophilus is one of the eight strains contained in VSL#3, the high-potency probiotic preparation that has been studied more extensively in inflammatory bowel conditions than perhaps any other commercial probiotic product. A randomized controlled trial published in Clinical Gastroenterology and Hepatology demonstrated that VSL#3—which includes S. thermophilus alongside multiple lactobacilli and bifidobacteria—significantly induced remission in patients with mild-to-moderately active ulcerative colitis compared with placebo.[7] Separately, research examining Lactic Acid Bacteria strains in acute diarrhea—including rotavirus diarrhea in children—has found that S. thermophilus-containing preparations reduce duration and severity compared with no treatment, consistent with the strain's ability to support intestinal barrier function and reduce pathogen adhesion.
While the individual contribution of S. thermophilus within multi-strain preparations cannot always be cleanly isolated, its specific protective effects on intestinal epithelial cells have been demonstrated in in vitro models showing resistance to pathogen adhesion and a reduction in pro-inflammatory cytokine signaling. This positions S. thermophilus as a mechanistically justified component of multi-strain probiotic formulations targeting gut inflammation.
Helicobacter pylori: A Role in Eradication Support
Helicobacter pylori is the gram-negative bacterium responsible for the majority of peptic ulcers and a recognized risk factor for gastric cancer. Standard antibiotic eradication therapy is increasingly complicated by antibiotic resistance, and there is growing research interest in probiotic adjunct strategies. Lactic Acid Bacteria, including S. thermophilus, have been examined in this context. The proposed mechanisms include competitive exclusion of H. pylori from the gastric epithelium and the production of lactic acid and bacteriocins that create a hostile environment for the pathogen. While S. thermophilus alone is not a standalone treatment for H. pylori, its inclusion in a comprehensive probiotic formula may support the broader microbial environment in which H. pylori thrives less readily.
Colorectal Cancer: An Emerging Research Area
Some of the most intriguing recent research on S. thermophilus concerns its potential role in colorectal cancer prevention. A study published in Scientific Reports examined the strain IDCC 2201 specifically and found that it significantly altered gut microbiota composition in a direction associated with reduced colorectal cancer risk—decreasing populations of pathobionts while increasing beneficial species and short-chain fatty acid producers.[8]
These findings are preliminary and drawn largely from animal and in vitro models. They do not constitute a clinical recommendation for probiotic use in cancer prevention. However, they add to the mechanistic rationale for S. thermophilus as a strain that does more than aid digestion—it actively shapes the microbial community in ways that appear to favor long-term gut health.
Supporting Your Gut Ecosystem With More Than One Strain
The research on S. thermophilus consistently shows its effects are amplified in combination with complementary strains. MicroBiome Restore includes S. thermophilus alongside 25 other evidence-selected strains—including Lactobacillus delbrueckii subsp. bulgaricus, its classic synergistic partner—at a combined 15 billion CFU per serving. Learn more about the rationale behind this approach in our guide to multi-strain probiotics without MCC.
Immune Modulation and Anti-Inflammatory Effects
Gene Expression Changes in Immune Cells
Perhaps the most striking evidence for S. thermophilus' immune effects comes from a study published in PLOS ONE that examined its direct impact on human peripheral blood mononuclear cells (PBMCs)—the white blood cells that mediate both innate and adaptive immune responses. Researchers found that exposure to S. thermophilus produced measurable changes in gene expression across multiple immune pathways, including upregulation of anti-inflammatory cytokine signaling and modulation of genes involved in T-cell differentiation.[4]
This is significant because it demonstrates that S. thermophilus doesn't merely passively occupy gut space—it actively communicates with the immune system at a molecular level. The gut-immune axis is mediated largely through pattern recognition receptors that detect bacterial surface components, and S. thermophilus' cell wall architecture and EPS layer appear to engage these receptors in ways that skew immune responses toward tolerance and resolution rather than chronic inflammation.
Postbiotics: Anti-Inflammatory Effects Even Beyond Live Bacteria
A body of research has established that S. thermophilus' anti-inflammatory effects persist even when the bacteria are heat-inactivated—meaning the strain functions as a postbiotic as well as a probiotic. A study published in an open-access pharmacological journal demonstrated that S. thermophilus inhibits the activity of endocannabinoid-degrading enzymes FAAH (fatty acid amide hydrolase) and MAGL (monoacylglycerol lipase), effectively elevating endocannabinoid tone and reducing pain and inflammatory signaling through the endocannabinoid system.[9] The endocannabinoid system is a lipid-based signaling network present throughout the gastrointestinal tract and skin, where it regulates inflammation, barrier function, and pain perception. By modulating this system, S. thermophilus may influence inflammatory responses not just in the gut but in peripheral tissues as well.
This mechanism partially explains why topical application of S. thermophilus-containing preparations has been studied in the context of skin disorders, including inflammatory conditions characterized by itching and barrier disruption. The strain's ability to support the endocannabinoid system's natural tone aligns with emerging research on probiotic management of skin disorders like eczema and rosacea—a connection explored in our article on the gut-skin axis.
A separate investigation published in PMC examined the anti-inflammatory properties of S. thermophilus heat-killed preparations in THP-1 macrophage models and confirmed significant reductions in pro-inflammatory cytokines including TNF-α and IL-6.[5] These findings reinforce the idea that this strain contributes meaningfully to overall inflammatory balance—and given the known gut-skin connection, the implications for those dealing with inflammatory skin disorders may be meaningful even when the probiotic is taken orally rather than applied topically.
Exercise-Induced Inflammation
One of the most unexpected applications of S. thermophilus research involves exercise recovery. A randomized, double-blind, placebo-controlled crossover trial published in PMC found that combined supplementation with Streptococcus thermophilus FP4 and Bifidobacterium breve BR03—both strains present in MicroBiome Restore—significantly attenuated the decline in peak force and range of motion following muscle-damaging eccentric exercise in healthy adults.[6]
The proposed mechanism involves the strains' ability to downregulate systemic inflammatory markers and support faster resolution of exercise-induced tissue damage. While this particular application is more niche than digestive support, it illustrates the systemic reach of a well-formulated probiotic containing S. thermophilus—effects that extend well beyond the gut wall itself.

How S. thermophilus Reduces Inflammation: Four Key Pathways
1. EPS-Mediated Immune Modulation: Exopolysaccharides interact with mucosal dendritic cells and macrophages in the human gut, promoting regulatory T-cell activity and reducing the production of pro-inflammatory cytokines like TNF-α and IL-6.
2. Endocannabinoid System Interaction: Inhibition of FAAH and MAGL enzymes elevates endocannabinoid tone throughout the gastrointestinal tract and peripheral tissues, producing downstream analgesic and anti-inflammatory effects.
3. Tight Junction Reinforcement: EPS and metabolic byproducts support the structural integrity of the intestinal epithelium, reducing bacterial endotoxin (LPS) translocation that drives systemic inflammatory signaling.
4. Bile Salts Resistance and Colonization: S. thermophilus demonstrates robust bile salts tolerance, allowing it to survive the hostile conditions of the upper gastrointestinal tract and reach the colon where colonization and immune signaling occur. This probiotic characteristic distinguishes it from more fragile lactic acid bacteria strains that are eliminated before reaching their target site.
Synergy Within a Multi-Strain Formula
The Classic Partnership: S. thermophilus and L. bulgaricus
The synergistic relationship between Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus is one of the most studied microbial partnerships in food science. These two organisms exhibit a phenomenon called proto-cooperation: S. thermophilus produces formic acid and CO₂ that stimulate L. bulgaricus growth, while L. bulgaricus generates amino acids through proteolysis that in turn support S. thermophilus proliferation. The result is a combined metabolic activity that neither achieves as efficiently alone.
Both strains are included in MicroBiome Restore, preserving this synergistic relationship in supplement form. This kind of deliberate strain co-formulation is one of the reasons the science of multi-strain probiotic selection matters—not all combinations produce complementary effects, and the evidence base for specific pairings should inform formula decisions.

Complementary Roles with Bifidobacteria and Other Lactobacilli
S. thermophilus occupies a distinct ecological niche within the human gut compared to the bifidobacteria it shares MicroBiome Restore with. Bifidobacteria, including Bifidobacterium longum subsp. longum and B. infantis, tend to colonize the colon and specialize in fermenting complex oligosaccharides, while S. thermophilus operates more prominently in the small intestine. This positional complementarity means the two groups of lactic acid bacteria support different segments of the gastrointestinal tract simultaneously rather than competing for the same niche.
Research on Bifidobacterium longum and Lactobacillus acidophilus individually demonstrates health effects that are mechanistically distinct from those of S. thermophilus—which is exactly the point. A formula that includes all three is addressing gut health across more dimensions simultaneously than any single strain could achieve.
The Role of Prebiotics in Supporting S. thermophilus
Like all probiotic strains, S. thermophilus requires fermentable substrate to maintain activity and support colonization. MicroBiome Restore includes a curated set of prebiotic fibers specifically selected for their compatibility with the formula's strains: acacia fiber, Jerusalem artichoke, maitake mushroom, fig fruit, bladderwrack, Norwegian kelp, and oarweed.
Acacia fiber, in particular, has been shown to selectively increase Lactobacillus and Streptococcus populations in the gut—a finding that directly supports the viability of S. thermophilus in the colon environment. Our article on acacia fiber and its prebiotic role in MicroBiome Restore examines this relationship in detail. The algae-based prebiotics—bladderwrack, Norwegian kelp, and oarweed—contribute fucoidan and other polysaccharides with both prebiotic and independent anti-inflammatory properties that complement what S. thermophilus itself produces. For more on the prebiotic foundation behind the formula, see our breakdown of Jerusalem artichoke as a prebiotic and maitake mushroom's role in gut health.
26 Strains. 9 Organic Prebiotics. No Unnecessary Fillers.
MicroBiome Restore combines Streptococcus thermophilus with 25 other evidence-selected probiotic strains at 15 billion CFU per serving—delivered in pullulan capsules without microcrystalline cellulose, magnesium stearate, or titanium dioxide.
Choosing a Supplement with Streptococcus thermophilus
Why Strain Verification Matters
Not all Streptococcus thermophilus strains are interchangeable. Research on the MCC0200 strain published findings from in vitro studies corroborated with genome analysis that characterized its specific probiotic characteristics—including acid tolerance, bile salts hydrolytic activity, and adhesion capacity to intestinal cell lines.[10] Strain-level differences in bile salts resistance determine how much of a given dose reaches the large intestine alive, making this probiotic characteristic one of the most practically important differentiators between strains. The probiotic potential of a given S. thermophilus preparation is therefore not a fixed value—it depends entirely on which strain was used, how it was manufactured, and whether the encapsulation protects it through the acidic gastrointestinal tract.
When evaluating a supplement that claims to include S. thermophilus, the label should identify the strain designation, the CFU count at time of manufacture or expiration, and ideally the third-party testing certifications that confirm potency is maintained through the product's shelf life. Understanding how to read probiotic supplement labels for hidden fillers and incomplete disclosures is a practical first step in making an informed choice.

Capsule Material: Not All Encapsulation Is Equal
The delivery mechanism matters more for probiotic survival than most consumers realize. S. thermophilus has been demonstrated to have reasonable gastric acid tolerance compared with many Lactobacillus species, but it still benefits from encapsulation that delays exposure to stomach acid. Standard gelatin capsules and many HPMC (hydroxypropyl methylcellulose) formulations provide minimal protection. The comparison between HPMC and pullulan capsules for gut health reveals that pullulan—a fermentation-derived polysaccharide—functions as a prebiotic in addition to providing delayed release, making it the only capsule material that actively supports the formula it contains.
What to Avoid in the Inactive Ingredients
The inactive ingredients in a probiotic can work directly against its purpose. Microcrystalline cellulose (MCC), one of the most common fillers in supplement manufacturing, has been associated with gut microbiome disruption in emerging research. Magnesium stearate, a ubiquitous flow agent, may impair nutrient absorption and alter membrane function in intestinal cells. These are not theoretical risks—they are reasons why choosing a multi-strain probiotic without microcrystalline cellulose is worth the additional effort when evaluating your options.
Timing and Consistency
The clinical research on S. thermophilus generally involves daily supplementation over weeks to months rather than acute single-dose interventions. This reflects the nature of microbiome modulation: meaningful, lasting changes in gut ecology require consistent probiotic input. Our comprehensive guide on the best time to take probiotics covers the evidence on timing relative to meals and how to maximize strain viability and colonization opportunity.
S. thermophilus in MicroBiome Restore: What Sets It Apart
MicroBiome Restore includes Streptococcus thermophilus as part of a 26-strain, 15-billion-CFU-per-serving formula with zero microcrystalline cellulose, zero magnesium stearate, and zero titanium dioxide. The prebiotics included in the formula—specifically acacia fiber and Jerusalem artichoke—have been selected in part for their demonstrated ability to support Streptococcus and Lactobacillus populations in the large intestine. The pullulan capsule provides delayed release and acts as a prebiotic substrate itself. This is what it looks like when every formulation decision has a scientific rationale.
Frequently Asked Questions
Is Streptococcus thermophilus safe to take as a supplement?
Yes. S. thermophilus is classified as GRAS (Generally Recognized As Safe) by the FDA and holds QPS (Qualified Presumption of Safety) status from the European Food Safety Authority, making it one of the most thoroughly reviewed microorganisms in the food and supplement industries. It has been consumed by humans in fermented dairy for thousands of years and has no known pathogenicity at the species level. Studies in both healthy adults and immunocompromised populations have not identified safety concerns associated with its consumption.[1]
Can Streptococcus thermophilus help with lactose intolerance?
The evidence is strong. Multiple clinical studies confirm that S. thermophilus produces beta-galactosidase—the enzyme that breaks down lactose—and releases it into the small intestine during digestion. This has been shown to significantly reduce lactose maldigestion in clinical trials measured by breath hydrogen tests.[2][3] This effect is most pronounced when S. thermophilus is consumed as part of a fermented product or in a high-viability probiotic supplement alongside food, allowing bacterial lysis to occur in the small intestine where lactase activity is needed.
Is S. thermophilus good for IBS?
It has been studied in the context of inflammatory bowel conditions, most prominently as one of eight strains in the VSL#3 preparation, which demonstrated efficacy in inducing remission in mild-to-moderate ulcerative colitis in a randomized controlled trial.[7] For IBS specifically, the picture is more complex—S. thermophilus contributes to gut barrier integrity and reduces gut inflammation, but IBS is a heterogeneous condition where individual strain responses vary. Its mechanisms suggest it is a useful component of a multi-strain formula targeting IBS, particularly when bloating and dysbiosis are involved. For more on evidence-based strain selection for conditions like SIBO, see our article on probiotics for SIBO.
What does Streptococcus thermophilus do in the gut?
It works through several mechanisms simultaneously: it produces beta-galactosidase to aid lactose digestion; manufactures exopolysaccharides (EPS) that support the mucus layer and tight junction integrity of the intestinal wall; modulates immune cell gene expression to reduce chronic inflammatory signaling; synthesizes folate; and ferments carbohydrates to produce lactic acid and short-chain fatty acids that lower colonic pH and support colonocyte health. In combination with compatible co-strains, it also exhibits synergistic metabolic activity that enhances the collective output of the formula.
How much Streptococcus thermophilus should I take?
Most clinical trials examining S. thermophilus benefits use preparations in the range of 10⁸ to 10¹⁰ colony-forming units (CFU) per dose, administered once or twice daily. MicroBiome Restore delivers 15 billion CFU per serving across its 26-strain blend, placing S. thermophilus within a meaningful therapeutic range as part of a comprehensive formula. There is no universally established minimum effective dose for this specific strain, as the research often uses it in multi-strain contexts. Consistency over weeks rather than single-dose supplementation appears to be the most important factor based on available evidence.
Does Streptococcus thermophilus survive the stomach?
S. thermophilus shows better acid tolerance than many mesophilic lactobacilli, particularly when consumed with or shortly after food—which raises gastric pH and reduces exposure time. Its thermal stability also extends to some degree of acid tolerance. High-quality encapsulation, such as the pullulan capsules used in MicroBiome Restore, further supports viability through the acidic stomach environment to deliver live organisms to the small intestine and colon where they exert their effects.
Conclusion: A Strain That Earns Its Place
The science on Streptococcus thermophilus is not new, but it is more expansive and evidence-based than most probiotic marketing would suggest. From its mechanistically understood role in lactose digestion and gut barrier support, to its immune-modulating effects at the gene expression level, to the emerging research on its anti-inflammatory postbiotic properties and colorectal health influence—this strain brings genuine scientific credibility to any formula it occupies.
What it does not bring is unnecessary risk. With GRAS and QPS designations, thousands of years of safe human consumption, and no known pathogenicity, S. thermophilus is among the most rigorously vetted probiotic organisms available today. The name sounds intimidating. The evidence is reassuring.
At BioPhysics Essentials, every strain in MicroBiome Restore earned its inclusion through the research—not through manufacturing convenience or cost savings. S. thermophilus is no exception. If you want to understand the full rationale behind the formula, our complete MicroBiome Restore guide walks through each ingredient decision in detail.

Ready to Experience a Probiotic That Does More?
MicroBiome Restore includes Streptococcus thermophilus alongside 25 other strains, 9 organic prebiotics, and 80+ trace minerals—delivered in a filler-free, pullulan capsule formula at 15 billion CFU per serving.
References
- EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards). (2013). Scientific Opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2013 update). EFSA Journal, 11(11), 3449. https://doi.org/10.2903/j.efsa.2013.3449
- Kolars, J. C., Levitt, M. D., Aouji, M., & Savaiano, D. A. (1984). Yogurt—an autodigestive source of lactose. New England Journal of Medicine, 310(1), 1–3. https://doi.org/10.1056/NEJM198401053100101
- Savaiano, D. A. (2014). Lactose digestion from yogurt: mechanism and relevance. American Journal of Clinical Nutrition, 99(5 Suppl), 1251S–1255S. https://doi.org/10.3945/ajcn.113.073023
- Dong, E., Yun, Y., Hossain, A., Liu, B., Teng, H., & Wang, J. (2021). Streptococcus thermophilus alters the expression of genes associated with innate and adaptive immunity in human peripheral blood mononuclear cells. PLOS ONE, 16(4), e0250321. https://doi.org/10.1371/journal.pone.0250321
- Iannone, A., Prencipe, F., Limieri, M., Montagna, I., & Palumbo, P. (2022). Streptococcus thermophilus: A source of postbiotics displaying anti-inflammatory effects in THP-1 macrophages. International Journal of Molecular Sciences, 23(19), 11080. https://doi.org/10.3390/ijms231911080
- Jäger, R., Purpura, M., Stone, J. D., Turner, S. M., Anzalone, A. J., Eimerbrink, M. J., Pane, M., Amoroso, C., Delay, E. R., & Brooks, J. R. (2016). Probiotic Streptococcus thermophilus FP4 and Bifidobacterium breve BR03 supplementation attenuates performance and range-of-motion decrements following muscle damaging exercise. Nutrients, 8(10), 642. https://doi.org/10.3390/nu8100642
- Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., & Tandon, R. K. (2009). The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clinical Gastroenterology and Hepatology, 7(11), 1202–1209.e1. https://doi.org/10.1016/j.cgh.2009.07.016
- Jeon, S. R., Chai, J. Y., Kim, C., & Lee, C. H. (2022). The impact of Streptococcus thermophilus IDCC 2201 on gut microbiota and its potential as a prophylactic agent for colorectal cancer. Scientific Reports, 12(1), 17620. https://doi.org/10.1038/s41598-022-22538-8
- Graziani, G., Prete, R., Tofalo, R., Schirone, M., Corsetti, A., & Ojetti, V. (2022). The anti-inflammatory and analgesic potential of the probiotic Streptococcus thermophilus via inhibition of endocannabinoid-degrading enzymes: a preliminary in vitro study. Exploration of Medicine, 3(4), 378–389. https://doi.org/10.37349/emed.2022.00099
- Gupta, V., & Garg, R. (2021). Unveiling the probiotic potential of Streptococcus thermophilus MCC0200: insights from in vitro studies corroborated with genome analysis. Frontiers in Cellular and Infection Microbiology, 11, 647749. https://doi.org/10.3389/fcimb.2021.647749


Share and get 15% off!
Simply share this product on one of the following social networks and you will unlock 15% off!